That's way more than what analysts expect.
It has been for days.
Pharmafarm is back in business.
For HUF 479 million this time.
Signs license and distribution agreement.
Sertorius buys 63,000 OTP shares this time.
Sertorius Fund aquires more than 43,000 OTP shares.
Women's Healthcare portfolio expanded.
Rating remains unchanged.
Hardly any of them expect a major decline.
The EBITDA and EPS estimates have also been upped.
To HUF 570 per share from HUF 600.
J.P. Morgan also cuts rating.
U.S. FDA rejects application by Allergan.
The share of property funds in the domestic investment market grew to 20.7% in July as assets managed...